Sarinnapha M Vasunilashorn1,2, Edward R Marcantonio3,4,5, Yun Gou5, Margaret A Pisani6, Thomas G Travison3,4,5, Eva M Schmitt5, Richard N Jones7, Sharon K Inouye3,4,5. 1. Beth Israel Deaconess Medical Center, Boston, MA, USA. svasunil@bidmc.harvard.edu. 2. Harvard Medical School, Boston, MA, USA. svasunil@bidmc.harvard.edu. 3. Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Harvard Medical School, Boston, MA, USA. 5. Hebrew Senior Life, Boston, MA, USA. 6. Yale School of Medicine, New Haven, CT, USA. 7. Warren Alpert Medical School of Brown University, Providence, RI, USA.
Abstract
BACKGROUND: The ability to determine which episodes of delirium are likely to lead to poor clinical outcomes has remained a major area of challenge. OBJECTIVE: To quantify delirium severity and course over an entire hospitalization using several measures, and to evaluate their predictive validity for 30- and 90-day outcomes post-discharge. DESIGN: Two prospective cohort studies. PARTICIPANTS: Analysis was conducted in two independent cohorts of adult patients aged ≥70. MAIN MEASURES: Nine delirium episode severity measures were examined: (1) measures reflecting delirium intensity (peak Confusion Assessment Method-Severity [CAM-S] and mean CAM-S score), (2) a measure reflecting delirium intensity and duration (sum of all CAM-S scores, sum of all CAM-S scores on delirium days only, peak CAM-S score x days with delirium), (3) measures requiring information on delirium duration and delirium at discharge (total number of delirium days, percentage of delirium days, delirium at discharge), and (4) a measure of cognitive change. Associations of the delirium episode severity measures with 30- and 90-day post-hospital outcomes (death, nursing home placement, and readmission) relevant to delirium were examined. KEY RESULTS: The delirium episode severity measure that required information on both delirium intensity and duration (sum of all CAM-S scores) was the most strongly associated with 30- and 90-day post-hospital outcomes. Using this measure, the relative risk [95 % confidence interval] for death at 30-days increased across levels of sum of all CAM-S scores from 1.0 (referent) to 2.1 [0.8, 5.4] for 'low,' to 2.9 [1.2, 7.1] for 'moderate,' to 6.4 [2.9, 14.0] for 'high' (p for trend <.01). CONCLUSIONS: The delirium episode severity measure that included both intensity and duration had the strongest association with important post-hospital outcomes.
BACKGROUND: The ability to determine which episodes of delirium are likely to lead to poor clinical outcomes has remained a major area of challenge. OBJECTIVE: To quantify delirium severity and course over an entire hospitalization using several measures, and to evaluate their predictive validity for 30- and 90-day outcomes post-discharge. DESIGN: Two prospective cohort studies. PARTICIPANTS: Analysis was conducted in two independent cohorts of adult patients aged ≥70. MAIN MEASURES: Nine delirium episode severity measures were examined: (1) measures reflecting delirium intensity (peak Confusion Assessment Method-Severity [CAM-S] and mean CAM-S score), (2) a measure reflecting delirium intensity and duration (sum of all CAM-S scores, sum of all CAM-S scores on delirium days only, peak CAM-S score x days with delirium), (3) measures requiring information on delirium duration and delirium at discharge (total number of delirium days, percentage of delirium days, delirium at discharge), and (4) a measure of cognitive change. Associations of the delirium episode severity measures with 30- and 90-day post-hospital outcomes (death, nursing home placement, and readmission) relevant to delirium were examined. KEY RESULTS: The delirium episode severity measure that required information on both delirium intensity and duration (sum of all CAM-S scores) was the most strongly associated with 30- and 90-day post-hospital outcomes. Using this measure, the relative risk [95 % confidence interval] for death at 30-days increased across levels of sum of all CAM-S scores from 1.0 (referent) to 2.1 [0.8, 5.4] for 'low,' to 2.9 [1.2, 7.1] for 'moderate,' to 6.4 [2.9, 14.0] for 'high' (p for trend <.01). CONCLUSIONS: The delirium episode severity measure that included both intensity and duration had the strongest association with important post-hospital outcomes.
Authors: Gail J McAvay; Peter H Van Ness; Sidney T Bogardus; Ying Zhang; Douglas L Leslie; Linda S Leo-Summers; Sharon K Inouye Journal: J Am Geriatr Soc Date: 2006-08 Impact factor: 5.562
Authors: Sharon K Inouye; Ying Zhang; Ling Han; Linda Leo-Summers; Richard Jones; Edward Marcantonio Journal: J Gen Intern Med Date: 2006-09-11 Impact factor: 5.128
Authors: Marieke J Schuurmans; Patricia I Deschamps; Susan W Markham; Lillie M Shortridge-Baggett; Sijmen A Duursma Journal: Res Theory Nurs Pract Date: 2003 Impact factor: 0.688
Authors: Daniel H J Davis; Donal T Skelly; Carol Murray; Edel Hennessy; Jordan Bowen; Samuel Norton; Carol Brayne; Terhi Rahkonen; Raimo Sulkava; David J Sanderson; J Nicholas Rawlins; David M Bannerman; Alasdair M J MacLullich; Colm Cunningham Journal: Am J Geriatr Psychiatry Date: 2014-08-15 Impact factor: 4.105
Authors: Sarinnapha M Vasunilashorn; Long H Ngo; Sharon K Inouye; Tamara G Fong; Richard N Jones; Simon T Dillon; Towia A Libermann; Margaret O'Connor; Steven E Arnold; Zhongcong Xie; Edward R Marcantonio Journal: Alzheimers Dement Date: 2020-01-04 Impact factor: 21.566
Authors: Richard N Jones; Sevdenur Cizginer; Laura Pavlech; Asha Albuquerque; Lori A Daiello; Kumar Dharmarajan; Lauren J Gleason; Benjamin Helfand; Lauren Massimo; Esther Oh; Olivia I Okereke; Patricia Tabloski; Laura A Rabin; Jirong Yue; Edward R Marcantonio; Tamara G Fong; Tammy T Hshieh; Eran D Metzger; Kristen Erickson; Eva M Schmitt; Sharon K Inouye Journal: JAMA Intern Med Date: 2019-02-01 Impact factor: 21.873
Authors: Annie M Racine; Tamara G Fong; Thomas G Travison; Richard N Jones; Yun Gou; Sarinnapha M Vasunilashorn; Edward R Marcantonio; David C Alsop; Sharon K Inouye; Bradford C Dickerson Journal: Neurobiol Aging Date: 2017-08-04 Impact factor: 4.673
Authors: Sarinnapha M Vasunilashorn; Tamara G Fong; Asha Albuquerque; Edward R Marcantonio; Eva M Schmitt; Douglas Tommet; Yun Gou; Thomas G Travison; Richard N Jones; Sharon K Inouye Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Sarinnapha M Vasunilashorn; Simon T Dillon; Sharon K Inouye; Long H Ngo; Tamara G Fong; Richard N Jones; Thomas G Travison; Eva M Schmitt; David C Alsop; Steven D Freedman; Steven E Arnold; Eran D Metzger; Towia A Libermann; Edward R Marcantonio Journal: J Am Geriatr Soc Date: 2017-05-26 Impact factor: 5.562
Authors: Annie M Racine; Tamara G Fong; Yun Gou; Thomas G Travison; Douglas Tommet; Kristen Erickson; Richard N Jones; Bradford C Dickerson; Eran Metzger; Edward R Marcantonio; Eva M Schmitt; Sharon K Inouye Journal: Alzheimers Dement Date: 2017-11-27 Impact factor: 21.566
Authors: Annie M Racine; Madeline D'Aquila; Eva M Schmitt; Jacqueline Gallagher; Edward R Marcantonio; Richard N Jones; Sharon K Inouye; Dena Schulman-Green Journal: Gerontologist Date: 2019-09-17